4//SEC Filing
Kunkel Lori Anne 4
Accession 0001549595-24-000068
CIK 0001549595other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:26 PM ET
Size
5.5 KB
Accession
0001549595-24-000068
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Award
Director Stock Option (right to buy)
2024-05-20+25,000→ 25,000 totalExercise: $16.19Exp: 2034-05-19→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 20, 2025, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:26 PM ET
- Size
- 5.5 KB